Page last updated: 2024-08-25

bathophenanthroline and Triple Negative Breast Neoplasms

bathophenanthroline has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brabec, V; Kasparkova, J; Kostrhunova, H; Novohradsky, V; Pracharova, J; Štarha, P; Trávníček, Z	1

Other Studies

1 other study(ies) available for bathophenanthroline and Triple Negative Breast Neoplasms

Article	Year
Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells. Dalton transactions (Cambridge, England : 2003), 2018, Sep-11, Volume: 47, Issue:35 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Osmium; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms	2018

Article

Year

Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.

Dalton transactions (Cambridge, England : 2003), 2018, Sep-11, Volume: 47, Issue:35

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Osmium; Phenanthrolines; Ruthenium; Triple Negative Breast Neoplasms

2018